DXS3:F:F-Xtrackers - S&P 500 Inverse Daily Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.124

Change

-0.05 (-0.86)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.49 (+1.86%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+1.01 (+2.01%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+24.90 (+4.45%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+1.58 (+2.92%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+4.37 (+4.36%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+5.15 (+2.19%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

-0.06 (-0.74%)

USD 40.89B
0ZC:F Zscaler Inc

+10.94 (+6.42%)

USD 37.92B

ETFs Containing DXS3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.87% 10% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.87% 10% F 37% F
Trailing 12 Months  
Capital Gain -20.41% 6% D- 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.41% 6% D- 26% F
Trailing 5 Years  
Capital Gain -49.48% 1% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -49.48% 1% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain -9.57% 8% B- 22% F
Dividend Return -9.57% 7% C- 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.06% 22% F 65% D
Risk Adjusted Return -47.71% 18% F 22% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.